SCHEMBL1720168

SCHEMBL1720168

COC(=O)SSCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8568913 0.98 MAPT (0.42)
SCHEMBL11616249 0.85 TSHR (0.35)
SCHEMBL421346 0.79
SCHEMBL125624 0.79
SCHEMBL19386249 0.77 TSHR (0.52)
SCHEMBL10067112 0.76 LMNA (0.32)
SCHEMBL11618480 0.76 EPHX1 (0.36)
SCHEMBL10435535 0.73
SCHEMBL11612026 0.72 EPHX1 (0.42)
SCHEMBL11613493 0.72 EPHX1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1617873-B1 Treatment of multi-drug resistant tumours by a conjugate of mitomycin C ALZA CORP (US) 2012-01-18 EP disclosed
US-7608687-B2 Releasable linkage and compositions containing same ALZA CORPORATION (US) 2009-10-27 US disclosed
US-7592307-B2 Releasable linkage and compositions containing same ALZA CORPORATION (US) 2009-09-22 US disclosed
US-20080279922-A1 Releasable linkage and compositions containing same ALZA CORPORATION 2008-11-13 US disclosed
US-20080152702-A1 Releasable linkage and compositions containing same ZALIPSKY SAMUEL 2008-06-26 US disclosed
US-7390780-B2 Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification ALZA CORPORATION (US) 2008-06-24 US disclosed
EP-1880736-A1 Releasable linkage and composition containing same Alza Corporation (US) 2008-01-23 EP disclosed
US-7303760-B2 Method for treating multi-drug resistant tumors ALZA CORPORATION (US) 2007-12-04 US disclosed
US-7285622-B2 Releasable linkage and compositions containing same ALZA CORPORATION (US) 2007-10-23 US disclosed
US-7276248-B2 Conjugate having a cleavable linkage for use in a liposome ALZA CORPORATION (US) 2007-10-02 US disclosed
US-20020192275-A1 Liposome composition for improved intracellular delivery of a therapeutic agent ALZA CORPORATION 2002-12-19 US disclosed
WO-2002076428-A1 LIPOSOME COMPOSITION FOR IMPROVED INTRACELLULAR DELIVERY OF A THERAPEUTIC AGENT ALZA CORPORATION (US) 2002-10-03 WO disclosed
US-20020128195-A1 Releasable linkage and compositions containing same ALZA CORPORATION 2002-09-12 US disclosed
CN-1355713-A Releasable bond and composition containing the same ALZA CORP (US) 2002-06-26 CN disclosed
US-6365179-B1 CONJUGATE FOR USE IN LIPOSOMAL DRUG-DELIVERY VEHICLE INCLUDING HYDROPHOBIC MOIETY SUITABLE FOR INCORPORATION INTO LIPOSOMAL LIPID BILAYER AND THERAPEUTIC DRUG COVALENTLY ATTACHED TO DITHIOBENZYL MOIETY IN ORTHO OR PARA POSITION ALZA CORPORATION 2002-04-02 US disclosed
US-6342244-B1 HYDROPHILIC POLYMER COVALENTLY YET REVERSIBLY LINKED TO A AMINE-CONTAINING LIGAND THROUGH A DITHIOBENZYL LINKAGE; MODIFICATION OF VARIOUS SUBSTRATES, SUCH AS POLYPEPTIDES, DRUGS AND LIPOSOMES; UPON CLEAVAGE OF THE LINKAGE, THE LIGAND ALZA CORPORATION 2002-01-29 US disclosed
EP-1173221-A2 RELEASABLE LINKAGE AND COMPOSITIONS CONTAINING SAME Alza Corporation (US) 2002-01-23 EP disclosed
EP-1173222-A2 CONJUGATE HAVING A CLEAVABLE LINKAGE FOR USE IN A LIPOSOME ALZA CORPORATION (US) 2002-01-23 EP disclosed
WO-2000064484-A2 CONJUGATE HAVING A CLEAVABLE LINKAGE FOR USE IN A LIPOSOME ALZA CORPORATION (US) 2000-11-02 WO disclosed
WO-2000064483-A2 RELEASABLE LINKAGE AND COMPOSITIONS CONTAINING SAME ALZA CORPORATION (US) 2000-11-02 WO disclosed